9th IAS Conference on HIV

From July 23 to 26, 2017, the Ninth IAS Conference on HIV Science, of which Inserm is a partner, will be held at the Palais des Congrès in Paris. For this edition, the International AIDS Society (IAS) has teamed up with ANRS, the autonomous agency of Inserm, to coordinate and fund research on HIV/AIDS and hepatitis.

The program will cover innovative approaches to HIV prevention, treatment and care. Various speakers, including Inserm researchers, will highlight the various advances in vaccines, new therapeutic approaches and prevention of HIV and hepatitis.

Yves Lévy, Inserm Chairman and CEO, will speak at the inaugural conference on Monday, July 24 on “Exploiting the immune system to prevent and control HIV infection”.

The scientific results of several Inserm researchers, including Dominique Costagliola, Patrizia Carrieri, Guillemette Antoni and Marie Jauffret-Roustide, will be presented at this conference.

Access the program for IAS 2017

Inserm press room 9th IAS Conference on HIV Link : https://presse.inserm.fr/en/9th-ias-conference-on-hiv/29017/

Medias

Researcher Contact

Dominique Costagliola Inserm research director and director of Inserm unit 1136 "Pierre Louis Institute of Epidemiology and Public Health" Team: “Clinical epidemiology of HIV infection: Therapeutic strategies and co-morbidities” +33 (0)6 15 19 03 79 dominique.costagliola@iplesp.upmc.fr Guillemette Antoni Inserm unit US19 “SC10: Therapeutic trials and infectious diseases” +33 (0)1 45 59 51 07 guillemette.antoni@inserm.fr Marie Jauffret-Roustide Inserm unit 988 "Cermes 3 - Center for Research in Medicine, Sciences, Health, Mental Health and Society” +33 (0)6 10 55 32 87 marie.jauffret-roustide@inserm.fr Patrizia Carrieri Inserm unit 912 "Economic and social sciences of health and processing of medical information" Team:"Environments, health systems and communicable diseases" pmcarrieri@aol.com

Press Contact

presse@inserm.fr

9th IAS Conference on HIV

Researcher Contact

Press Contact

New Antibiotics Developed by Inserm and Université de Rennes 1

A novel, more effective method for diagnosing Alzheimer’s disease

Elaboration et validation de l’iBox, le premier outil universel de prédiction du risque de perte de rein greffé basé sur l’intelligence artificielle.

Du nouveau dans l’apprentissage automatique via des systèmes biologiques